Healios KK (TSE:4593) FFO


TSE:4593 Healios KK TSE:4593
53 GF Score
Price 円261.00
GF Value 円56.72
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Healios KK FFO?

FFO (Funds from operations) only applies to REITs.

TSE:4593
53GF Score
Healios KK TSE:4593
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Healios KK (TSE:4593) Overvalued in 2026?

Based on GuruFocus' analysis, Healios KK stock appears to be overvalued. The current stock price of 円261.00 is trading 360.2% above its estimated GF Value™ of 円56.72. GuruFocus considers Healios KK to be Significantly Overvalued.

Key valuation signals for TSE:4593:

  • FFO:
  • GF Value™: 円56.72 vs. price of 円261.00 (360.2% above fair value)
  • GF Score™: 53/100 with 5 warning signs

No single metric tells the full story. See the TSE:4593 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Healios KK Business Description

Other Exchanges HLOSF:USA6VX:Germany
Address 1-1-2 Yurakucho, Hibiya Mitsui Tower 12Floor, Work Styling, Chiyoda-ku, Tokyo, JPN, 100-0006
Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy. The company develops next-generation cell therapies using a proprietary gene-edited induced pluripotent stem cell (iPSC) platform, with programs targeting immuno-oncology, ophthalmology, liver diseases, ischemic stroke, and acute respiratory distress syndrome.
53GF Score

Get the complete analysis for TSE:4593

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円261.00
Price
円56.72
GF Value